Novo Nordisk to Cut 9,000 Jobs as Competition Rises
Novo Nordisk, the company behind Ozempic and Wegovy, will cut 9,000 jobs globally as competition increases and the pharmaceutical industry adapts to new challenges.
The UK has launched a national plan for 400,000 new clean energy jobs by 2030, aligning with global efforts by the US and EU to train workers and boost pay in the green economy.
The European Commission launches a €22.5 million call to recruit top researchers from around the world for long-term postdoctoral positions in Europe.
Novo Nordisk, the company behind Ozempic and Wegovy, will cut 9,000 jobs globally as competition increases and the pharmaceutical industry adapts to new challenges.